299 related articles for article (PubMed ID: 25938632)
1. Elevated Lipoprotein(a) Does Not Cause Low-Grade Inflammation Despite Causal Association With Aortic Valve Stenosis and Myocardial Infarction: A Study of 100,578 Individuals from the General Population.
Langsted A; Varbo A; Kamstrup PR; Nordestgaard BG
J Clin Endocrinol Metab; 2015 Jul; 100(7):2690-9. PubMed ID: 25938632
[TBL] [Abstract][Full Text] [Related]
2. Effect of APOE ε Genotype on Lipoprotein(a) and the Associated Risk of Myocardial Infarction and Aortic Valve Stenosis.
Kritharides L; Nordestgaard BG; Tybjærg-Hansen A; Kamstrup PR; Afzal S
J Clin Endocrinol Metab; 2017 Sep; 102(9):3390-3399. PubMed ID: 28651346
[TBL] [Abstract][Full Text] [Related]
3. Elevated Lipoprotein(a) Levels, LPA Risk Genotypes, and Increased Risk of Heart Failure in the General Population.
Kamstrup PR; Nordestgaard BG
JACC Heart Fail; 2016 Jan; 4(1):78-87. PubMed ID: 26656145
[TBL] [Abstract][Full Text] [Related]
4. Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population.
Kamstrup PR; Tybjærg-Hansen A; Nordestgaard BG
J Am Coll Cardiol; 2014 Feb; 63(5):470-7. PubMed ID: 24161338
[TBL] [Abstract][Full Text] [Related]
5. Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation.
Varbo A; Benn M; Tybjærg-Hansen A; Nordestgaard BG
Circulation; 2013 Sep; 128(12):1298-309. PubMed ID: 23926208
[TBL] [Abstract][Full Text] [Related]
6. PCSK9 R46L Loss-of-Function Mutation Reduces Lipoprotein(a), LDL Cholesterol, and Risk of Aortic Valve Stenosis.
Langsted A; Nordestgaard BG; Benn M; Tybjærg-Hansen A; Kamstrup PR
J Clin Endocrinol Metab; 2016 Sep; 101(9):3281-7. PubMed ID: 27218270
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein(a) and risk of myocardial infarction--genetic epidemiologic evidence of causality.
Kamstrup PR; Tybjærg-Hansen A; Nordestgaard BG
Scand J Clin Lab Invest; 2011 Apr; 71(2):87-93. PubMed ID: 21231777
[TBL] [Abstract][Full Text] [Related]
8. Plasma adiponectin levels and risk of heart failure, atrial fibrillation, aortic valve stenosis, and myocardial infarction: large-scale observational and Mendelian randomization evidence.
Nielsen MB; Çolak Y; Benn M; Mason A; Burgess S; Nordestgaard BG
Cardiovasc Res; 2024 Feb; 120(1):95-107. PubMed ID: 37897683
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology.
Nordestgaard BG; Langsted A
J Lipid Res; 2016 Nov; 57(11):1953-1975. PubMed ID: 27677946
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein(a) is linked to atherothrombosis and aortic valve stenosis independent of C-reactive protein.
Thomas PE; Vedel-Krogh S; Kamstrup PR; Nordestgaard BG
Eur Heart J; 2023 Apr; 44(16):1449-1460. PubMed ID: 36805188
[TBL] [Abstract][Full Text] [Related]
11. Milk intake is not associated with ischaemic heart disease in observational or Mendelian randomization analyses in 98,529 Danish adults.
Bergholdt HK; Nordestgaard BG; Varbo A; Ellervik C
Int J Epidemiol; 2015 Apr; 44(2):587-603. PubMed ID: 26085675
[TBL] [Abstract][Full Text] [Related]
12. Oxidized Phospholipids and Risk of Calcific Aortic Valve Disease: The Copenhagen General Population Study.
Kamstrup PR; Hung MY; Witztum JL; Tsimikas S; Nordestgaard BG
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1570-1578. PubMed ID: 28572160
[TBL] [Abstract][Full Text] [Related]
13. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction.
Kamstrup PR; Tybjaerg-Hansen A; Steffensen R; Nordestgaard BG
JAMA; 2009 Jun; 301(22):2331-9. PubMed ID: 19509380
[TBL] [Abstract][Full Text] [Related]
14. Role of lipoprotein (a) and LPA KIV2 repeat polymorphism in bicuspid aortic valve stenosis and calcification: a proof of concept study.
Sticchi E; Giusti B; Cordisco A; Gori AM; Sereni A; Sofi F; Mori F; Colonna S; Fugazzaro MP; Pepe G; Nistri S; Marcucci R
Intern Emerg Med; 2019 Jan; 14(1):45-50. PubMed ID: 30099661
[TBL] [Abstract][Full Text] [Related]
15. Extreme lipoprotein(a) levels and improved cardiovascular risk prediction.
Kamstrup PR; Tybjærg-Hansen A; Nordestgaard BG
J Am Coll Cardiol; 2013 Mar; 61(11):1146-56. PubMed ID: 23375930
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein(a): fasting and nonfasting levels, inflammation, and cardiovascular risk.
Langsted A; Kamstrup PR; Nordestgaard BG
Atherosclerosis; 2014 May; 234(1):95-101. PubMed ID: 24632508
[TBL] [Abstract][Full Text] [Related]
17. Obesity as a Causal Risk Factor for Aortic Valve Stenosis.
Kaltoft M; Langsted A; Nordestgaard BG
J Am Coll Cardiol; 2020 Jan; 75(2):163-176. PubMed ID: 31948645
[TBL] [Abstract][Full Text] [Related]
18. Elevated Lipoprotein(a) and Risk of Ischemic Stroke.
Langsted A; Nordestgaard BG; Kamstrup PR
J Am Coll Cardiol; 2019 Jul; 74(1):54-66. PubMed ID: 31272552
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein(a) isoform size, lipoprotein(a) concentration, and coronary artery disease: a mendelian randomisation analysis.
Saleheen D; Haycock PC; Zhao W; Rasheed A; Taleb A; Imran A; Abbas S; Majeed F; Akhtar S; Qamar N; Zaman KS; Yaqoob Z; Saghir T; Rizvi SNH; Memon A; Mallick NH; Ishaq M; Rasheed SZ; Memon FU; Mahmood K; Ahmed N; Frossard P; Tsimikas S; Witztum JL; Marcovina S; Sandhu M; Rader DJ; Danesh J
Lancet Diabetes Endocrinol; 2017 Jul; 5(7):524-533. PubMed ID: 28408323
[TBL] [Abstract][Full Text] [Related]
20. High Lipoprotein(a) and Low Risk of Major Bleeding in Brain and Airways in the General Population: a Mendelian Randomization Study.
Langsted A; Kamstrup PR; Nordestgaard BG
Clin Chem; 2017 Nov; 63(11):1714-1723. PubMed ID: 28877919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
